Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer's disease

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Kobayashi, Yodai ^a   Sugahara, Hirosuke ^a   Shimada, Kousuke ^b   Mitsuyama, Eri ^a   Kuhara, Tetsuya ^a   Yasuoka, Akihito ^b   Kondo, Takashi ^b   Abe, Keiko ^b,c   Xiao, Jin Zhong ^a  

^a MORINAGA MILK INDUSTRY CO LTD   (Japan)

^b KANAGAWA ACADEMY OF SCIENCE AND TECHNOLOGY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ALZHEIMER DISEASE; ANIMAL; BIFIDOBACTERIUM BREVE; COGNITIVE DEFECT; HIPPOCAMPUS; INTESTINE FLORA; MALE; METABOLISM; MICROBIOLOGY; MOUSE;

ALZHEIMER DISEASE; ANIMALS; BIFIDOBACTERIUM BREVE; COGNITIVE DYSFUNCTION; GASTROINTESTINAL MICROBIOME; HIPPOCAMPUS; MALE; MICE; PROBIOTICS;

EID: 85031898289     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-13368-2     Document Type: Article

References (48)

1. Glenner, G. G., & Wong, C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-90 (1984).
2. McNaull, B. B. A., Todd, S., McGuinness, B., & Passmore, A. P. Inflammation and anti-inflammatory strategies for Alzheimer's Disease - A mini-review. Gerontology 56, 3-14 (2010).
3. Wyss-Coray, T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat. med 12, 1005-1015 (2006).
4. Jack, C. R., et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119-128 (2010).
5. Pistollato, F., et al. Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. Nutr. Rev. 74, 624-634 (2016).
6. Gareau, M. G., Sherman, P. M., & Walker, W. A. Probiotics and the gut microbiota in intestinal health and disease. Nat. Rev. Gastroenterol. Hepatol. 7, 503-514 (2010).
7. Kondo, S., et al. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Biosci. Biotechnol. Biochem. 74, 1656-61 (2010).
8. Sivan, A., et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350, 1084-9 (2015).
9. Savilahti, E. Probiotics in the Treatment and Prevention of Allergies in Children. Biosci. Microflora 30, 119-128 (2011).
10. Kafshdooz, T., et al. Role of Probiotics in Managing of Helicobacter Pylori Infection: A Review. Drug Res. (Stuttg). 67, 88-93 (2016).
11. Matsumoto, M., Kurihara, S., Kibe, R., Ashida, H., & Benno, Y. Longevity in mice is promoted by probiotic-induced suppression of colonic senescence dependent on upregulation of gut bacterial polyamine production. PLoS One 6, e23652 (2011).
12. Sampson, T. R., & Mazmanian, S. K. Review control of brain development, function, and behavior by the microbiome. Cell Host Microbe 17, 565-576 (2015).
13. Liu, Y. W., et al. Psychotropic effects of Lactobacillus plantarum PS128 in early life-stressed and naïve adult mice. Brain Res. 1631, 1-12 (2016).
14. Distrutti, E., et al. Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the agerelated deficit in LTP. PLoS One 9, e106503 (2014).
15. Akbari, E., et al. Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's Disease: a randomized, double-blind and controlled trial. Front. Aging Neurosci. 8, 256 (2016).
16. Ait-Belgnaoui, A., et al. Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice. Neurogastroenterol. Motil. 26, 510-20 (2014).
17. Takeda, S., et al. Validation of Aβ1-40 administration into mouse cerebroventricles as an animal model for Alzheimer disease. Brain Res. 1280, 137-147 (2009).
18. Kempuraj, D., et al. Neuroinflammation induces neurodegeneration. J. Neurol. Neurosurg. spine 1, 1003 (2016).
19. Lee, Y. J., Han, S. B., Nam, S.-Y., Oh, K.-W., & Hong, J. T. Inflammation and Alzheimer's disease. Arch. Pharm. Res. 33, 1539-1556 (2010).
20. Tan, M. G., et al. Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease. J. Neurosci. Res. 88, 1157-1169 (2009).
21. Wang, S., Qaisar, U., Yin, X., & Grammas, P. Gene expression profiling in Alzheimer's disease brain microvessels. J. Alzheimers. Dis. 31, 193-205 (2012).
22. Arisi, I., et al. Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection. J. Alzheimers. Dis. 24, 721-38 (2011).
23. Wirz, K. T. S., et al. Cortical beta amyloid protein triggers an immune response, but no synaptic changes in the APPswe/PS1dE9 Alzheimer's disease mouse model. Neurobiol. Aging 34, 1328-1342 (2013).
24. Leal, G., Bramham, C. R., & Duarte, C. B. InVitamins and hormones 104, 153-195 (2017).
25. Fung, T. C., Olson, C. A., & Hsiao, E. Y. Interactions between the microbiota, immune and nervous systems in health and disease. Nat. Neurosci. 20, 145-155 (2017).
26. Bravo, J. A., et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. 108, 16050-16055 (2011).
27. Bercik, P., et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol. Motil. 23, 1132-1139 (2011).
28. Tracey, K. J., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458-462 (2000).
29. Koopman, F. A., et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc. Natl. Acad. Sci. 113, 8284-8289 (2016).
30. Kirchner, A., Birklein, F., Stefan, H., & Handwerker, H. O. Left vagus nerve stimulation suppresses experimentally induced pain. Neurology 55, 1167-71 (2000).
31. Morris, G. L., & Mueller, W. M. Long-Term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. Neurology 53, 1731-5 (1999).
32. Rush, A. J., et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol. Psychiatry 58, 347-354 (2005).
33. Kamiya, T., et al. Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. Gut 55, 191-196 (2006).
34. Horii, Y., et al. Effects of intraduodenal injection of Lactobacillus brevis SBC8803 on autonomic neurotransmission and appetite in rodents. Neurosci. Lett. 539, 32-7 (2013).
35. Holmes, E., Li, J. V., Marchesi, J. R., & Nicholson, J. K. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab. 16, 559-564 (2012).
36. Rothhammer, V., et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 22, 586-97 (2016).
37. Rooks, M. G., & Garrett, W. S. Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol. 16, 341-352 (2016).
38. Louveau, A., et al. Structural and functional features of central nervous system lymphatic vessels. Nature 523, 337-341 (2015).
39. Morrison, D. J., & Preston, T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7, 189-200 (2016).
40. Smith, P. M., et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569-573 (2013).
41. Kumar, M., Kissoon-Singh, V., Coria, A. L., Moreau, F., & Chadee, K. Probiotic mixture VSL#3 reduces colonic inflammation and improves intestinal barrier function in Muc2 mucin-deficient mice. Am. J. Physiol. Gastrointest. Liver Physiol. 312, 34-45 (2017).
42. Schaeffer, E. L., Figueiro, M., & Gattaz, W. F. Insights into Alzheimer disease pathogenesis from studies in transgenic animal models. Clinics 66, 45-54 (2011).
43. Saito, T., et al. Single App knock-in mouse models of Alzheimer's disease. Nat. Neurosci. 17, 661-663 (2014).
44. Min, L. J., et al. Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice. PLoS One 12, e0171515 (2017).
45. Love, M. I., Huber, W., & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq 2. Genome Biol. 15, 550 (2014).
46. Dennis, G., et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4, P3 (2003).
47. Odamaki, T., et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol. 16, 90 (2016).
48. Tsukahara, T., et al. High-sensitivity detection of short-chain fatty acids in porcine ileal, cecal, portal and abdominal blood by gas chromatography-mass spectrometry. Anim. Sci. J. 85, 494-498 (2014).